Page last updated: 2024-10-21

4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol and Thrombopenia

4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol has been researched along with Thrombopenia in 2 studies

4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol: inhibitor of GABA uptake systems; RN given refers to parent cpd

Research Excerpts

ExcerptRelevanceReference
"Hereditary thrombocytopenia is a heterogeneous group of congenital disorders with a wide range of symptoms depending on the severity of platelet dysfunction or thrombocytopenia."1.72Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm. ( Jeong, DJ; Kim, MJ; Kwon, S; Kwon, SR; Lee, DS; Lee, YE; Park, JH; Yun, J, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Kwon, SR1
Kim, MJ1
Lee, YE1
Yun, J1
Jeong, DJ1
Park, JH1
Kwon, S1
Lee, DS1
Cornish, N1
Aungraheeta, MR1
FitzGibbon, L1
Burley, K1
Alibhai, D1
Collins, J1
Greene, D1
Downes, K1
Westbury, SK1
Turro, E1
Mumford, AD1

Other Studies

2 other studies available for 4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol and Thrombopenia

ArticleYear
Novel THPO variant in hereditary thrombocytopenia: A potential candidate variant for predisposition to myeloid neoplasm.
    PloS one, 2022, Volume: 17, Issue:12

    Topics: Disease Susceptibility; Humans; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms;

2022
Monoallelic loss-of-function THPO variants cause heritable thrombocytopenia.
    Blood advances, 2020, 03-10, Volume: 4, Issue:5

    Topics: Humans; Isoxazoles; Thrombocytopenia; Thrombopoietin

2020